Subject : nall Pharmaceutical Acquires Patent on Protein Engineering
Date
2009-04-29
Visit
4781
Hanall Pharmaceutical announced that they purchased a global patent on “high-throughput protein engineering technology” from the French firm, Nautilus Biotech.
Hanall Pharmaceutical paid the contract fees of $2.5 million to Nautilus Biotech in 2007 and concluded a contract for purchasing the rights of high-throughput protein engineering technology.
Nautilus Biotech currently owns 50 other related patents.
DOWON INTERNATIONAL
5F. Shinwon Bldg. 823-14, Yeoksam-dong, Kangnam-ku, SEOUL, 135-080
KOREA
PHONE : 82-2-501-3106 FAX : 82-2-501-3109 e-mail : patyellow@dowon.com
Patent News
